Skip to main content
. 2023 Apr 26;11(12):2657–2669. doi: 10.12998/wjcc.v11.i12.2657

Table 1.

Predictive factors for disease recurrence after therapy withdrawal

Poor disease prognostic features CD/UC: Young age at diagnosis and male sex
CD: Ileal, colonic or perianal disease; stricturing/penetrating disease
UC: Pancolitis
Challenging disease control before withdrawal Many relapses requiring add-on steroids
Anti-TNF escalation while already on
Need for surgery or anti-TNF post-operative prophylaxis
Biochemical disease activity High CRP levels
Elevated fecal calprotectin
Elevated white cells or neutrophil count
Low hemoglobin levels
Endoscopic disease activity No mucosal healing
Radiological CD activity No transmural healing
IFX trough levels High IFX trough levels in monotherapy
Low IFX trough levels in combination therapy with an imunomodulator

CD: Crohn’s disease; UC: Ulcerative colitis; TNF: Tumor necrosis factor; CRP: C-reactive protein; IFX: Infliximab.